The primary outcome was mortality, New York Heart Association function classification, heart rate, 6-minute walk test, hospitalization or rehospitalization. Besides, left ventricular ejection fraction, left ventricular end-diastolic dimension, Cardiac index, heart rate, systolic blood pressure, DBP, BNP, cardiac minute volume, NT-BNP, and other indicators were also assessed as secondary results. We will also conclude the number and proportion of adverse events in both groups to assess the safety of SFI application in clinic.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.